Bhi Flu Plus Tablet
FDA Label NDC 62795-1008

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Bhi Flu Plus (NDC 62795-1008). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, inactive ingredients, purpose, uses, directions, warnings, keep out of reach of children, bhi flu +, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Each tablet contains: *Aconitum napellus 4X, *Anas barbariae, hepatis et cordis extractum 200 CK, *Bryonia alba 4X, *Eupatorium perfoliatum 4X, *Ipecacuanha 6X, *Lachesis mutus 12X, *Phosphorus 8X, *Pulsatilla 6X, *Sulphur 8X, Zincum gluconicum 3X, Zincum metallicum 3X 27.3 mg each.

*Natural Ingredients

Inactive Ingredients

Lactose, Magnesium stearate

Purpose

Relieves Flu Symptoms:

• Body Aches

• Fatigue

• Headache

Uses

For the temporary relief of minor body aches, fatigue, headache

Directions

At first sign of symptoms:

 Adults and children 4 years and older:

1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

Standard dosage:

Adults and children 4 years andolder:

3 tablets per day, taking 1 tablet every 4 to 6 hours.

For children under 4, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow.

Warnings

If pregnant or breast-feeding, ask a healthprofessional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should beconsulted. Do not use if known sensitivity to BHI Flu+ or any of its ingredients exists

Keep Out Of Reach Of Children

Keep out of reach of children.

* Please review the disclaimer below.